Skip to content
Search

Latest Stories

Pharmacy leaders call for reassurance of community pharmacy's inclusion in NHS workforce plan

Pharmacy leaders have called for reassurance that the workforce plan, expected by April 2023, will cover the entirety of the pharmacy workforce across the health service, including in community pharmacies.

A joint letter has been signed by representatives from 14 pharmacy organisations which highlights that with continued pressures on services, it is more important than ever to support the pharmacy workforce so that the staff needed to deliver patient care now and into the future can be recruited, trained and retained.


Mark Koziol, Pharmacists' Defence Association (PDA) Chairman said: “Our pharmacist members practise across the entire health system and have the potential to do far more to help patients and improve public health, but they can only do so safely if they are in appropriately staffed workplaces. This is a workforce issue, so it is important that the Government works with representatives of the pharmacist workforce, and of their employers, to get a suitably agreed plan in place.”

Thorrun Govind, English Pharmacy Board Chair, Royal Pharmaceutical Society (RPS), said: “It will be crucial to use the skills of all our health professions to support the NHS recovery, reduce health inequalities, manage the growing cost of long-term conditions, and deliver best value from medicines.

"Pharmacists are increasingly working across care settings and as such the whole of the pharmacy workforce must be included in the Government’s upcoming long-term workforce plan and supported by investment in education and training.

"Pharmacy teams across the health service are under enormous pressure and as well as support for frontline staff now, the workforce plan must also look to the future and how we can make the most of the next generation of pharmacist independent prescribers to enhance patient care."

The letter was co-signed by:

  • Dr Leyla Hannbeck, Chief Executive, Association of Independent Multiple Pharmacies
  • Claire Steele, President, Association of Pharmacy Technicians UK
  • Joseph Williams, Chair, British Oncology Pharmacy Association
  • Priyanka Patel, President, British Pharmaceutical Students’ Association
  • Roz Gittins, President, College of Mental Health Pharmacy
  • Malcolm Harrison, Chief Executive, Company Chemists’ Association
  • Nathan Burley, President, Guild of Healthcare Pharmacists
  • Mark Lyonette, Chief Executive, National Pharmacy Association
  • Janet Morrison OBE, Chief Executive, Pharmaceutical Services Negotiating Committee
  • Mark Koziol, Chairman, Pharmacists’ Defence Association
  • Prof Katie Maddock, Chair, Pharmacy Schools Council
  • Dr Graham Stretch, President, Primary Care Pharmacy Association
  • Thorrun Govind, English Pharmacy Board Chair, Royal Pharmaceutical Society
  • Mohamed Rahman, Chair, UK Clinical Pharmacy Association

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less